Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
For the many years, the Commonwealth Games platform has ushered in the era of several…
According to the current set of data, the Boomerang Nebula is the coldest location in…
Throughout the history, the Commonwealth Games have been synonymous with sporting excellence and cultural diversity…
The Indian Navy has kicked off Operation Southern Readiness 26-2, an exercise on multi-nation maritime…
Maharashtra is going to open the first AI-powered bird sanctuary of India at Thane Creek…
France passed a new law to prohibit the children aged under 15 years from using…